Vanguard Global Advisers
BSX icon

Vanguard Global Advisers’s Boston Scientific BSX Stock Holding History

Vanguard Global Advisers’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142M Buy
3,337,790
+93,552
+3% +$5.08M 0.07% 220
2026
Q1 		$204M Buy
+3,244,238
New +$260M 0.11% 141

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Global Advisers's BSX Position: Q2 2026 in Review

Vanguard Global Advisers increased its Boston Scientific (BSX) stake by 2.9% in Q2 2026, buying an estimated $5.08M and bringing the position to 3,337,790 shares worth $142M. The position accounts for 0.07% of the portfolio, ranked #220.

Vanguard Global Advisers first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $204M in Q1 2026. 1,381 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Vanguard Global Advisers held 3,337,790 shares of Boston Scientific worth $142M as of Q2 2026.
  • Vanguard Global Advisers bought 93,552 Boston Scientific shares in Q2 2026, an estimated $5.08M.
  • Boston Scientific made up 0.07% of Vanguard Global Advisers's portfolio in Q2 2026, its #220 holding.
  • Vanguard Global Advisers first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Boston Scientific position peaked at $204M in Q1 2026.
  • 1,381 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.